Product Recalls in Indiana

Product recalls affecting Indiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Indiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 938 recalls have been distributed to Indiana in the last 12 months.

53,528 total recalls
938 in last 12 months

Showing 49021–49040 of 53,528 recalls

DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Vitamin B-Buildup Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy Recalled by...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Buprenorphine 0.3 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Tripelennamine 20 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Taurine 100 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Diclazuril 10 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Ketamine 100 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Metabolase Injection Recalled by Lowlite Investments, Inc. D/B/A Olympia...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml Recalled by Lowlite...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Dexpanthenol 250 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Atropine Sulfate 50 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Oxytocin 20 units/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Medroxyprogesterone 150 mg/ml Injection Recalled by Lowlite Investments,...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Ceftiofur GM vial 50 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Estradiol Cypionate 10 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Detomidine 10 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Diphenhydramine 50 mg/ml Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Phentolamine 20 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Cal-Phos 1000 Injection Recalled by Lowlite Investments, Inc. D/B/A Olympia...

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 29, 2013· Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Recalled Item: Adenosine-Mono-Phosphate Injection Recalled by Lowlite Investments, Inc....

The Issue: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund